Roseanne and Ambien: Racism won't Be a Side Effect, But There Are Many, Many Others
The
Roseanne saga took an unexpected turn in the week because the actress returned
to Twitter to elucidate that the tweet that led to the cancellation of her show
was sent out while she was on Ambien.
Sanofi,
the drug company that creates the drug, fired back a tweet of their own.
“People
of all races, religions, and nationalities work on Sanofi a day to enhance the
lives of individuals around the world,” the corporate said.
“While
all pharmaceutical treatments have side effects, racism isn't a known side
effect of any Sanofi medication.” By mid-day, #Ambien was one of the highest
trends on Twitter.
It
maybe true that racism isn’t a side effect, but that doesn’t mean there aren’t
many, many other side effects to the drug.
In
fairness, it might have required quite an epic Twitter thread for the corporate
to list all of them.
In my book The Sleep Revolution, I spent the higher part of a chapter writing
about so-called sleep aids (just because you’re not awake doesn’t mean you’re
asleep) and therefore the very real dangers they pose, which can outlive the
present Twitter feud.
So
whether or not you've got a while suddenly freed up by the cancellation of the
Roseanne reboot, here’s an abridged version of that chapter.
SLEEPLESSNESS AND SLEEPING PILLS: A MATCH MADE IN BURNOUT HEAVEN?
An entire industry has arisen to facilitate our attempts to urge more sleep.
In
us, quite 55 million prescriptions for sleeping pills were written just in
2014, with sales topping $1 billion.
A
2013 Centers for Disease Control report stated that 9 million Americans—4
percent of all adults—use prescription sleeping pills.
It also found that
ladies are bigger users of sleeping pills than men; that sleeping-pill
consumption increases with age and education, which white adults consume quite
the other racial group.
I
asked several sleep experts what they thought of the 4 percent number from the
CDC, and therefore the general conclusion was that the survey number involved
significant underreporting.
A
National Sleep Foundation poll found startlingly high rates of sleep aid usage
among women, with 29 percent reporting that they use a sleep aid of some kinda
minimum of a couple of nights hebdomadally.
The survey by Parade magazine of quite fifteen thousand people found that 23 percent
of respondents took sleeping pills once every week and 14 percent took them
nightly.
the matter is global: in 2014, people around the world spent a
staggering $58 billion on sleep-aid products, a figure projected to rise to
$76.7 billion by 2019.
Not
surprisingly, the utilization of sleeping pills is highest among those that
regularly get but five hours of sleep an evening.
For
the drug industry that stands to take advantage of today’s sleep crisis,
business is sweet and therefore the future looks bright.
But
the strength of this market is simply a mirrored image of the depth of the
matter.
And
although marketers use the soothing term “sleep aids,” burnout is that a necessary condition that feeds the sleep-aid market.
“In
twenty years, people will reminisce on the sleeping- pill era as we now
reminisce on the acceptance of cigarette smoking,” Jerome Siegel, director of
UCLA’s Center for Sleep Research told me.
“Movies
and television glamorized smoking. Advertisements, often with doctors or actors
posing as doctors, were wont to sell cigarettes.
”Only
after a few years and lots of studies linking cigarettes to carcinoma and other
diseases did the govt step in to manage tobacco advertising.
So
we may have moved beyond the age of Joe Camel and advertisements proclaiming
“More doctors smoke Camels than the other cigarette!” and “Give your throat a
vacation . . . Smoke a fresh cigarette,” but as Siegel put it, “history appears
to be repeating itself.
The chronic use of sleeping pills is an ongoing public
health disaster.”
Sleep
difficulties can become serious medical problems, as I discuss within the Sleep
Disorders chapter.
For
the overwhelming majority folks, however, sleep difficulties are a life-style
problem.
Yet we tend to treat all our sleep-related woes an equivalent way: with a pill. this is often hubris on the size of Greek mythology.
We expect as if by magic,
to wrestle sleep into submission.
This
isn’t accidental. Combine the marketing power of the fashionable pharmaceutical industry with a client market that has, potentially, every fatigued and burned
out worker—which is to mention nearly every worker—and you’ve got the makings
of the juggernaut that's the fashionable sleep-aid industry.
As Matthew Wolf- Meyer put it within the Slumbering
Masses, by “empowering medical practitioners, pharmaceuticals, and caffeine as
mediators in individuals’ relationships with sleep,” we've created a world
where “rather than a mild sovereign, sleep has become demonized and rendered an object of medical and scientific control.”
As
numerous folks blow out in our efforts to stay up in today’s high-pressure,
always-on world, we’ve made it easier and easier for the pharmaceutical
industry to tighten its grip on us and expand its reach.
Instead
of questioning how we live our lives, we fall prey to stylish marketing that
promises us health, happiness, sleep, and energy.
And who wants to be the
naysayer, the Luddite who rejects such progress? an excellent deal of ingenious
and insidious brainpower, alongside billions of dollars, goes into selling us
an answer that doesn’t actually solve our problems but only disguises and
prolongs them.
The most common pharmaceutical weapon we use to knock ourselves out is that the
drug zolpidem, which you almost certainly know as Ambien.
It
accounts for quite two-thirds of the sleeping pills sold within us.
It
is also sold under the soothing names Intermezzo, Sublinox, Zolfresh, and
Hypnogen.
That the last one is a component peculiarly apt since zolpidem is part of a category of
medicine referred to as hypnotics, which work to induce and lengthen the
duration of sleep.
Of
the 55 million prescriptions written for sleeping pills within us in 2014, 38
million were for zolpidem, accounting for sales of quite $320 million.
Lunesta,
another hypnotic, marketed with a seductive green butterfly logo, had quite
$350 million in sales within us in 2014, which figure doesn't include the generic version, eszopiclone, which generated another $43 million.
When
you hear the stories of individuals who became hooked on sleeping pills, you
realize that they really shouldn’t be called sleeping pills in the least.
Because
we now know that simply not being awake doesn’t necessarily mean you’re
actually asleep.
It’s
not the clean, binary, game the drug manufacturers would have us believe.
This
is why sleeping pills aren’t the answer to our sleep-deprivation crisis—they’re
another crisis masquerading as an answer, offering a false promise that takes
us beyond the advantages of real, restorative sleep.
Harvard
school of medicine professor Patrick Fuller explained to me the difference
between natural sleep and drug-induced sleep.
Sleeping
pills typically target just one of the various different chemical systems
employed by the brain as a part of the sleep process, which “necessarily
produces an imbalance within the chemical signaling by which the brain achieves
normal sleep and should limit restorative slow-wave sleep.
The
newer drugs like Ambien produce more naturalistic sleep but can have side
effects, albeit rarely, like sleep eating and sleepwalking, which by definition
aren't a neighborhood of normal sleep behavior.”
This
limbo state, once we aren't really awake but not really asleep, may result in
behaviors starting from the harmless and humorous to the disturbing and
dangerous.
And
a part of the danger is that you simply will quite likely haven't any memory of
whatever you are doing.
The
Today show’s Julia Sommerfeld was a daily user of Ambien until she
describes as her “wake-up call.
”
Her Mastercard company called to report suspicious activity on her
account—nearly $3,000 charged to the shop Anthropologie at 2 a.m. Her initial
reaction—a fraud! was quickly disproven, within the sort of an e-receipt at the
highest of her inbox: she had been the perpetrator of an Ambien-induced online
shopping spree.
On
other occasions, while on Ambien, she had also consumed large quantities of
sugar right out of the bag devoured two of her sons’ decorated Easter eggs,
and written an embarrassing email to her boss.
What
finally got her to kick the hypnotic habit was her husband invoking their
toddler son.
“How
are you able to make certain you’d never hurt Jude?” he asked.
“What
if you made the decision to place him within the car?” actually, during a
University of Washington study, people that took generics of Ambien, Desyrel,
or Restoril was nearly twice more in danger of being involved during a driving
accident.
In
response to growing concerns, the FDA in 2013 cut the recommended dose of zolpidem
in half—in half!—for women and commenced requiring stronger warning labels
highlighting the risks of driving an automobile after taking extended-release
versions of the drug.
it had been a big step forward—as well as a dramatic,
unequivocal acknowledgment of how the drug manufacturers are allowed to take
advantage of a sleep-deprived public for therefore long.
Ambien
has also been used as a defense in criminal trials—a pharmaceutical version of
the “Twinkie defense.”
On The Fix, a site about recovery and addiction, Allison
McCabe told the story of Lindsey Schweigert, a thirty-one-year-old working for
a contractor.
Returning
from a business trip exhausted, she took one dose of generic Ambien.
Several
hours later, when she emerged from her zombie state, she was in police custody.
She’d
gotten out of bed, filled the bath and left the water running, taken her dog
out, climbed into her car, and, while driving, collided with another car.
She
failed a sobriety test after falling 3 times when asked to steer a line.
The
police charged her with driving under the influence.
Prosecutors
sought a sentence of six months, but Schweigert’s lawyer pointed to the warning the label on the Ambien she took and argued that she belonged within the hospital,
not jail.
The label read: After taking Ambien, you'll rise up out of bed while not being
fully awake and do an activity that you simply don't know you're doing.
the subsequent morning, you'll not remember that you simply did anything during the
night. . . . Reported activities include: driving a car (“sleep-driving”),
making and eating food, talking on the phone, having sex, sleepwalking.
Put
aside for a flash the absurdity of this label and therefore the incontrovertible fact that it exists.
Or
file it under Warning Labels Apparently Written by The Onion.
The
charges were dropped, though Schweigert was left with a suspended license and
nearly $10,000 in lawyers’ fees.
The
more of those stories I hear, the more shocked I'm at the number of individuals
who walk off from such incidents with similar consequences—a suspended license,
a financial burden, but ultimately nothing more.
Because
of the FDA warning, the results of Ambien use are treated as a side effect, not
as a criminal offense.
I
asked Ted Olson, a former US lawman, to elucidate why something that might be a
criminal offense in one context isn't in another.
“Criminal
laws aren't well-suited for prosecutions in these sorts of cases,” he
explained, “because of the problem in articulating standards for impairment
from various sorts of medication and, for that matter, for driving while tired,
sleep-deprived, emotionally distracted, et cetera.
0 comments:
Post a Comment